The VA and DoD are not “loss leader” channels. They are high-value, margin-stable, influence-rich markets where a single, well-executed...

Pharmaceutical manufacturers frequently misinterpret market opportunity within the distinct VA patient population by directly applying...

We know both VA and DoD partner with Kaiser - but how do these health systems actually compare? If you’re investing in Kaiser Permanente,...

Bottom Line: Understanding the mechanisms in which a community care provider can request extended or new medical treatments is core...

Bottomline: The VA Community Care program, while crucial for expanding veteran healthcare access, can result in reimbursement...

Bottom Line: The Department of Defense (DoD) is frequently the first federal payer to formally assess newly FDA-approved pharmaceutical...

This side-by-side chart highlights the key distinctions between the VA healthcare system and Medicare, including eligibility, coverage...

Our team recently published Part II in a 3-part series aimed at helping drug manufactures gain an updated view of VA and DOD drug...

Bottom Line: The VA's updated presumptive conditions list expanding coverage for Gulf War and Post-9/11 veterans necessitates...

Bottom Line: Serving 2.8 million veterans at a $23.9 billion cost in FY2023, the VA Community Care Program expands healthcare access by...

Bottom Line: The VA's short-term community pharmacy Rx access isn't as open-ended as many assume. The Urgent/Emergent formulary contains...

Bottom Line: The VA formulary balances quality of care with cost-effectiveness by considering clinical evidence, veteran needs, and budget constraints to ensure best and appropriate access to affordable medications for the veteran population. The Department of Veterans Affairs (VA) formulary is a detailed list of medications approved for use in the VA healthcare system to optimize pharmaceutical care for veterans by promoting safety, effectiveness, and cost-efficiency. Formul